Cara Therapeutics, Inc. (CARA)
15.96
-0.69 (-4.14%)
Inactive · Last trade price on Apr 15, 2025
Cara Therapeutics Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Revenue Revenue Growth | 7.14 | 7.14 | 20.97 | 41.87 | 23.03 | 135.08 |
Revenue Growth | -65.96% | -65.96% | -49.92% | 81.81% | -82.95% | 579.28% |
Gross Profit Gross Profit Growth | -29.25 | -29.25 | -92.58 | -56.14 | -58.54 | 28.01 |
Operating Income Operating Income Growth | -55.78 | -55.78 | -121.5 | -87.54 | -89.08 | 5.39 |
Net Income Net Income Growth | -70.87 | -70.87 | -118.51 | -85.47 | -88.44 | 8.41 |
Earnings Per Share EPS Growth | -46.60 | -46.60 | -78.79 | -57.36 | -62.78 | 6.39 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Investments Cash & Investments Growth | 37.9 | 37.9 | 100.76 | 156.75 | 236.79 | 251.49 |
Total Debt Total Debt Growth | 44.45 | 44.45 | 43.17 | 1.92 | 3.67 | 5.28 |
Net Cash (Debt) Net Cash Growth | -6.55 | -6.55 | 57.59 | 154.83 | 233.12 | 246.22 |
Net Cash Growth | - | - | -62.80% | -33.58% | -5.32% | 15.14% |
Net Cash Per Share Net Cash Per Share Growth | -4.30 | -4.30 | 38.29 | 103.89 | 165.46 | 184.99 |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Cash Flow Operating Cash Flow Growth | -60.92 | -60.92 | -92.08 | -78.73 | -60.09 | -5.49 |
Capital Expenditures CapEx Growth | -1.05 | -1.05 | -2.38 | -0.04 | -0.04 | -0.35 |
Free Cash Flow Free Cash Flow Growth | -61.96 | -61.96 | -94.45 | -78.77 | -60.13 | -5.84 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Gross Margin | - | - | - | -134.09% | -254.19% | 20.74% |
Operating Margin | -781.58% | -781.58% | -579.43% | -209.08% | -386.85% | 3.99% |
Pretax Margin | -998.53% | -998.53% | -565.21% | -204.16% | -384.06% | 5.71% |
Profit Margin | -992.95% | -992.95% | -565.21% | -204.16% | -384.06% | 6.23% |
FCF Margin | -868.19% | -868.19% | -450.46% | -188.15% | -261.10% | -4.32% |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
PE Ratio | - | - | - | - | - | 89.65 |
PS Ratio | 3.40 | 3.92 | 1.93 | 13.78 | 28.28 | 5.58 |